The U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.

Quant rankings for the upcoming earnings calendar show strength concentrated in consumer discretionary and select industrial and health care names, while weakness is more pronounced across health care ...

CHELMSFORD — Six Chelmsford High School seniors were honored as Lions Pride/Rotary Students of the Month for February, Principal Stephen Murray announced.

Indiana’s representation on Capitol Hill took center stage in the nation’s capital this week as Senators Todd Young and Jim Banks issued a stark warning: the ...

China’s track record calls into question the country’s long-term commitment to permanently end the illicit trade of fentanyl precursors.

On March 2, 2026, Exelixis, Inc. (NASDAQ:EXEL) saw its price target from RBC Capital lowered from $46 to $43. The firm’s Sector Perform rating was maintained on the stock.

Construction is now underway on a new biotechnology and innovation center at Claflin University, a project leaders say will transform how students learn and prepare for future careers. For sophomore ...

The Edmonds School District Board of Directors prioritized financial policy updates and foster care guidelines during its regular meeting March 24. The board focused heavily on unfinished and new ...

This royalty-focused biotech with a broad drug portfolio reported a notable insider sale amid strong stock performance.

In a groundbreaking medical achievement, the surgical team at Xijing Hospital, led by Professor Qin Weijun and guided by Professor Dou Kefeng, successfully performed a multigene-edited ...

Kailera Therapeutics filed for an initial public offering. The obesity care biotechnology company, which is developing a group of GLP-1-based treatment candidates, said it would use proceeds from the ...